Koyfin Home > Directory > Health Care > Apellis Pharmaceuticals Inc > EBITDA Margin

Apellis Pharmaceuticals Inc EBITDA Margin Chart (APLS)

Apellis Pharmaceuticals Inc annual/quarterly EBITDA Margin from 2019 to 2019. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
Other Margins & Efficiency Metrics:
  • Apellis Pharmaceuticals Inc Return on Capital % for the quarter ending September 09, 2018 was -37.36 a -28.40% increase of 10.61 year over year
  • Apellis Pharmaceuticals Inc Return on Equity % for the quarter ending September 09, 2018 was -67.63 a -34.01% increase of 23.00 year over year
View Chart On Koyfin